Earnings Feed
Start Free
Gritstone bio, Inc.·4/A

Dec 3, 4:43 PM ET

Jones Erin 4/A

4/A · Gritstone bio, Inc. · Filed Dec 3, 2021

Insider Transaction Report

Form 4/AAmended
Period: 2021-10-01
Gritstone bio, Inc.GRTS
Jones Erin
EVP, CHIEF OPERATING OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2021-10-01$0.34/sh+1,000$345→ 46,900 total
  • Sale

    Common Stock

    [F1][F2]
    2021-10-01$10.68/sh−1,000$10,680→ 45,900 total
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2021-10-04$0.34/sh+1,000$345→ 46,900 total
  • Sale

    Common Stock

    [F1][F2]
    2021-10-04$10.71/sh−1,000$10,710→ 45,900 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F3]
    2021-10-01−1,000→ 34,971 total
    Exercise: $0.34Exp: 2026-05-17→ Common Stock (1,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F3]
    2021-10-04−1,000→ 33,971 total
    Exercise: $0.34Exp: 2026-05-17→ Common Stock (1,000 underlying)
Footnotes (3)
  • [F1]The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
  • [F2]Includes 25,900 Restricted Stock Units which are subject to vesting.
  • [F3]Fully exercisable.
Signature
/s/ Rahsaan Thompson, Attorney-in-Fact for Erin Jones|2021-12-03

Documents

1 file
  • 4
    doc1.xml

    FORM 4/A